skip to main content
Idioma:
Primo Search
Clear Search Box
Search in: Busca Geral
Busca Avançada
Busca por Índices

Yindanxinnaotong, a Chinese compound medicine, synergistically attenuatesatherosclerosis progress

Cheng, Long ; Pan, Guo-feng ; Zhang, Xiao-dong ; Wang, Jian-lu ; Wang, Wan-dan ; Zhang, Jian-yong ; Wang, Hui ; Liang, Ri-xin ; Sun, Xiao-bo

Scientific reports, 2015-07, Vol.5 (1), Article 12333 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
  • Título:
    Yindanxinnaotong, a Chinese compound medicine, synergistically attenuatesatherosclerosis progress
  • Autor: Cheng, Long ; Pan, Guo-feng ; Zhang, Xiao-dong ; Wang, Jian-lu ; Wang, Wan-dan ; Zhang, Jian-yong ; Wang, Hui ; Liang, Ri-xin ; Sun, Xiao-bo
  • É parte de: Scientific reports, 2015-07, Vol.5 (1), Article 12333
  • Descrição: Abstract Yindanxinnaotong (YD), a traditional Chinese medicine, has been introduced toclinical medicine for more than a decade, while its pharmacological properties arestill not to be well addressed. This report aimed to explore theanti-atherosclerosis properties and underlying mechanisms of YD. We initiallyperformed a computational prediction based on a network pharmacology simulation,which clued YD exerted synergistically anti-atherosclerosis properties by vascularendothelium protection, lipid-lowering, anti-inflammation and anti-oxidation. Theseoutcomes were then validated in atherosclerosis rats. The experiments providedevidences indicating YD’s contribution in this study included, (1)significantly reduced the severity of atherosclerosis, inhibited reconstruction ofthe artery wall and regulated the lipid profile; (2) enhanced antioxidant power,strengthened the activity of antioxidant enzymes and decreased malondialdhydelevels; (3) significantly increased the viability of umbilical vein endothelialcells exposed to oxidative stress due to pretreatment with YD; (4) significantlyreduced the level of pro-inflammatory cytokines; (5) significantly down-regulatedNF-kB/p65 and up-regulated IkB in the YD-treated groups. Overall, these resultsdemonstrated that YD intervention relieves atherosclerosis through regulatinglipids, reducing lipid particle deposition in the endothelial layer of artery,enhancing antioxidant power and repressing inflammation activity by inhibiting thenuclear factor-kappa B signal pathway.
  • Idioma: Inglês
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.